Yavuz Sultan Selim Akgul, Burcu Eren Cengiz, Gulsah Gunes Sahin, Derya Kocaslan, Neziha Ozlem Deveci, Sibel Akin
{"title":"比较 SARC-F 和 Ishii 评分在筛查 2 型糖尿病老年人肌肉疏松症中的应用：我们应该使用哪种筛查工具？","authors":"Yavuz Sultan Selim Akgul, Burcu Eren Cengiz, Gulsah Gunes Sahin, Derya Kocaslan, Neziha Ozlem Deveci, Sibel Akin","doi":"10.1007/s13410-024-01385-7","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Sarcopenia is common in older adults, and type 2 diabetes mellitus (DM), highly prevalent in older adults, is a risk factor for sarcopenia. Early detection of sarcopenia is vital for the implementation of preventive and therapeutic measures.</p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>We aimed to compare the SARC-F questionnaire and Ishii score screening methods for sarcopenia in patients with type 2 DM.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>This cross-sectional study was conducted on 462 older adults with diabetes aged ≥ 60. Muscle mass and strength were assessed using the BIA device and handgrip dynamometer. Sarcopenia was defined in line with the European Sarcopenia Working Group 2 (EWGSOP2). The SARC-F questionnaire and Ishii score in screening for sarcopenia were compared.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The median age was 72 (67–76) for males and 68 (65–74) for females. The prevalence of sarcopenia based on the Ishii score, SARC-F, and EWGSOP2 was 28.4%, 40.9%, and 61.9%, respectively. The sensitivities of Ishii score and SARC-F in screening for sarcopenia were 84% and 47%, respectively. The Ishii score and SARCF specificities were 67% and 69%, respectively. PPV and NPV for the Ishii score were 79% and 45%, respectively. The PPV and NPV for the SARC-F were 71% and 55%, respectively. The AUC values of the Ishii score and SARC-F were 0.790 and 0.598, respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The Ishii score can be used in daily practice to screen for sarcopenia in older adults with type 2 DM.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":"41 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of SARC-F and Ishii score in screening for sarcopenia in older adults with type 2 diabetes mellitus: which screening tool should we use?\",\"authors\":\"Yavuz Sultan Selim Akgul, Burcu Eren Cengiz, Gulsah Gunes Sahin, Derya Kocaslan, Neziha Ozlem Deveci, Sibel Akin\",\"doi\":\"10.1007/s13410-024-01385-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Background</h3><p>Sarcopenia is common in older adults, and type 2 diabetes mellitus (DM), highly prevalent in older adults, is a risk factor for sarcopenia. Early detection of sarcopenia is vital for the implementation of preventive and therapeutic measures.</p><h3 data-test=\\\"abstract-sub-heading\\\">Objective</h3><p>We aimed to compare the SARC-F questionnaire and Ishii score screening methods for sarcopenia in patients with type 2 DM.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>This cross-sectional study was conducted on 462 older adults with diabetes aged ≥ 60. Muscle mass and strength were assessed using the BIA device and handgrip dynamometer. Sarcopenia was defined in line with the European Sarcopenia Working Group 2 (EWGSOP2). The SARC-F questionnaire and Ishii score in screening for sarcopenia were compared.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>The median age was 72 (67–76) for males and 68 (65–74) for females. The prevalence of sarcopenia based on the Ishii score, SARC-F, and EWGSOP2 was 28.4%, 40.9%, and 61.9%, respectively. The sensitivities of Ishii score and SARC-F in screening for sarcopenia were 84% and 47%, respectively. The Ishii score and SARCF specificities were 67% and 69%, respectively. PPV and NPV for the Ishii score were 79% and 45%, respectively. The PPV and NPV for the SARC-F were 71% and 55%, respectively. The AUC values of the Ishii score and SARC-F were 0.790 and 0.598, respectively.</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusion</h3><p>The Ishii score can be used in daily practice to screen for sarcopenia in older adults with type 2 DM.</p>\",\"PeriodicalId\":50328,\"journal\":{\"name\":\"International Journal of Diabetes in Developing Countries\",\"volume\":\"41 1\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Diabetes in Developing Countries\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s13410-024-01385-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13410-024-01385-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Comparison of SARC-F and Ishii score in screening for sarcopenia in older adults with type 2 diabetes mellitus: which screening tool should we use?
Background
Sarcopenia is common in older adults, and type 2 diabetes mellitus (DM), highly prevalent in older adults, is a risk factor for sarcopenia. Early detection of sarcopenia is vital for the implementation of preventive and therapeutic measures.
Objective
We aimed to compare the SARC-F questionnaire and Ishii score screening methods for sarcopenia in patients with type 2 DM.
Methods
This cross-sectional study was conducted on 462 older adults with diabetes aged ≥ 60. Muscle mass and strength were assessed using the BIA device and handgrip dynamometer. Sarcopenia was defined in line with the European Sarcopenia Working Group 2 (EWGSOP2). The SARC-F questionnaire and Ishii score in screening for sarcopenia were compared.
Results
The median age was 72 (67–76) for males and 68 (65–74) for females. The prevalence of sarcopenia based on the Ishii score, SARC-F, and EWGSOP2 was 28.4%, 40.9%, and 61.9%, respectively. The sensitivities of Ishii score and SARC-F in screening for sarcopenia were 84% and 47%, respectively. The Ishii score and SARCF specificities were 67% and 69%, respectively. PPV and NPV for the Ishii score were 79% and 45%, respectively. The PPV and NPV for the SARC-F were 71% and 55%, respectively. The AUC values of the Ishii score and SARC-F were 0.790 and 0.598, respectively.
Conclusion
The Ishii score can be used in daily practice to screen for sarcopenia in older adults with type 2 DM.
期刊介绍：
International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
